Skip to content
Open access

tRNA-derived second messengers confer bacterial immunity

Oct 2026 · bioRxiv · 0 citations · 41 references
Medicine Biology

TL;DR

A nuclease-driven immune signaling pathway in which tRNA cleavage generates a specific small molecule that triggers cell death in response to RNA-guided transcript recognition in prokaryotes is reported.

Abstract

Bacterial small-molecule messengers that function in diverse immune signaling pathways have been thought to derive strictly from biosynthesis using nucleotide and cofactor substrates. Here we report a nuclease-driven immune signaling pathway in which tRNA cleavage generates a specific small molecule that triggers cell death in response to RNA-guided transcript recognition in prokaryotes. We identify a class of type VI-B CRISPR systems in which the RNA-guided nuclease Cas13 and its accessory transmembrane protein, 2TMβ, are co-encoded in an operon and are jointly required for bacteriophage defense. Upon target RNA recognition, Cas13 activates 2TMβ by producing mono- and dinucleotide messengers bearing 2′,3′-cyclic uridine phosphate ends by tRNA cleavage. Activated 2TMβ destroys infected cells by forming a multimeric complex that disrupts cell membranes to mediate cell death. These findings demonstrate RNA-programmed tRNA cleavage for second-messenger biogenesis, revealing a new logic for prokaryotic immune signaling.

Read PDF

Similar papers

Open access Oct 2026

Aminoacylated tRNA tails trigger auxiliary bacterial immunity

It is reported that aminoacylated tRNA tails cleaved during an immune response in bacteria serve as diffusible signals that trigger auxiliary immunity and establish aminoacylated tRNA fragments as cellular signaling molecules.

Yan Yan, Balwina Koopal, Sobita Kunwar et al. · 0 citations
Review Open access Oct 2026

Sensing a problem here: nucleotide signaling in immunity.

How receptor architecture, supramolecular assembly, and antagonism determine signal meaning and how newly defined defense systems invert conventional signaling logic by sensing the loss rather than the production of an immune nucleotide are discussed.

Jocelyn Leon Padilla, E. Ednacot, Benjamin R. Morehouse · 0 citations
Open access Sep 2026

A Noncontiguous Code for RNA-Guided DNA Recognition at the Origin of CRISPR-Cas

The discovery of Viral Interference Programmable Repeat systems consisting of a Vipr protein ancestral to the earliest CRISPR-Cas effectors and VIPR RNAs (vrRNAs) comprising alternating GGY/NN motifs suggests that adaptive immunity originated from ancient warfare between viruses.

Peter H. Yoon, Kenneth J. Loi, Z. Zhang et al. · 3 citations
Open access Sep 2026

A self-limiting dimeric TIR effector specialised for type III CRISPR-mediated immunity

Antiviral defence systems frequently utilise cyclic nucleotide second messengers. A prominent example is the type III CRISPR-Cas system, which generates cyclic oligoadenylates (cOA) on detecting viral RNA. cOA molecules can bind and activate a wide range of effectors to provide antiviral defence. In both prokaryotes an...

Yu Sun, Stephen McMahon, S. Synowsky et al. · 0 citations
Review Open access Sep 2026

Flipons, Noncoding Transcripts and Retroelements: A Universal Host Defense

Recent findings showing how these integrated host responses are driven by, and exploit, the retrotransposon invasion of animal genomes are focused on.

Alan Herbert · 0 citations
Review Open access Oct 2026

ISG15 Is a Key Multidirectional Regulator of Cytosolic RNA- and DNA-Sensing Pathways and Type I Interferon Feedback Loops

Activation of cytosolic RNA and DNA sensing pathways that normally recognize viral nucleic acids triggers the expression and release of type I interferons (IFN-I). This release drives the expression of interferon-stimulated genes (ISGs) that activate acute inflammation and counteract viral replication at various stages...

Maleana G. White, Sergey Iordanskiy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.